National Comprehensive Cancer Network



About NCCN

Multiple Myeloma/Systemic Light Chain Amyloidosis/Waldenstrm's Macroglobulinemia Panel - Disclosures as of 2/26/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Melissa Alsina, MD

None

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Ortho Biotech Products, L.P.

None

None

4/10/2013

Kenneth C. Anderson, MD

None

Celgene Corporation;
Onyx Pharmaceuticals, Inc.;
Gilead Sciences;
sanofi-aventis U.S.

acetylon;
oncopep

acetylon;
oncopep

2/21/2013

William Bensinger, MD

None

Celgene Corporation;
Genzyme Corporation;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

4/5/2013

J. Sybil Biermann, MD

None

None

None

None

12/9/2012

Jason C. Chandler, MD

None

Onyx Pharmaceuticals, Inc.

None

None

2/26/2013

Adam D. Cohen, MD

None

Bristol-Myers Squibb Company;
Celgene Corporation

None

Celgene Corporation

8/13/2012

Steven Devine, MD

Genzyme Corporation

Novartis Pharmaceuticals Corporation

None

None

5/14/2013

Benjamin Djulbegovic, MD, PhD

None

None

None

None

4/16/2014

Edward A. Faber, Jr., DO, MS

None

sanofi-aventis U.S.

None

None

5/28/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Cristina Gasparetto, MD

None

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

5/22/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Francisco Hernandez-Ilizaliturri, MD

None

Amgen Inc.;
Celgene Corporation

None

None

9/5/2013

Carol Ann Huff, MD

None

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

11/18/2013

Adetola Kassim, MD, MS

None

Celgene Corporation

None

None

4/17/2014

Amrita Y. Krishnan, MD, FACP

Celgene Corporation;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.

Celgene Corporation;
Genentech, Inc.;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.

Celgene Corporation;
Onyx Pharmaceuticals, Inc.;
Pharmacyclics

None

9/6/2013

Rashmi Kumar, PhD

None

None

None

None

5/28/2013

Michaela Liedtke, MD

None

None

None

Celgene Corporation

3/18/2014

Joan S. McClure, MS

None

None

None

None

8/13/2013

Ruby Meredith, MD, PhD

None

None

None

None

4/5/2013

Noopur Raje, MD

Amgen Inc.;
Eli Lilly and Company;
Acetylon

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

None

None

9/6/2013

Dorothy Shead, MS

None

None

None

None

8/19/2013

Seema Singhal, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Onyx Pharmaceuticals, Inc.

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

5/20/2013

George Somlo, MD

None

Celgene Corporation;
Genentech, Inc.;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Abraxane;
Roche Laboratories, Inc.;
Roche Laboratories, Inc.

None

None

7/12/2013

Keith Stockerl-Goldstein, MD

None

Celgene Corporation;
Millennium Pharmaceuticals, Inc.

None

None

5/23/2013

Steven P. Treon, MD, PhD

None

None

None

None

1/16/2014

Donna M. Weber, MD

None

Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
proteolix

None

None

9/26/2013

Joachim Yahalom, MD

None

None

None

None

10/17/2013